Population-Based Analysis of Cause-Specific Mortality in Older Esophageal Cancer Patients Treated With Conformal Radiation Therapy or Intensity Modulated Radiation Therapy : Outcomes/Health Services Research

s h lin,na zhang,j godby,jingdai wang,g d marsh,zhongxing liao,ritsuko komaki,lap ho,wayne l hofstetter,stephen g swisher,linda s elting,sharon h giordano

DOI: https://doi.org/10.1016/j.ijrobp.2014.08.261

2014-01-01

Abstract:While Intensity Modulated Radiation Therapy (IMRT) is increasingly being adopted for the treatment of esophageal cancer (EC), conformal radiation therapy (CRT) remains the standard of care due to the paucity of evidence to support the use of IMRT. We evaluated the outcomes of IMRT vs CRT in the general population using SEER-Medicare and Texas Cancer Registry (TCR) Medicare datasets. Non-metastatic EC patients ≥ 66 years diagnosed between 2002 and 2009 without second cancers within 1 year of diagnosis and with full Medicare but no HMO coverage within 12 months before and after diagnosis were included in the analysis. We defined radiation by claims (CPT codes: IMRT, HCPCS 77418, G0174; CRT, HCPCS: 77401-77416) within 6 months of diagnosis. The cause-specific and overall mortality rates were evaluated using Kaplan-Meier life test and multivariate (MVA) Cox proportional hazard model. A total of 2578 patients met the inclusion criteria (CRT=2265; IMRT=313). Except for marital status and SEER region, both radiation cohorts were well balanced for various patient, tumor, and treatment characteristics, including the distribution of the use of IMRT vs CRT in urban/metro or rural areas. IMRT use increased from 2.6% in 2002 to 30% in 2009, while CRT use decreased from 97.4% in 2002 to 70% in 2009. In unadjusted analysis, all-cause mortality, EC-specific mortality, and cardiac mortality were significantly reduced in the IMRT group (all: 52.4% vs 74.5%, P